NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.73

05 Jan
2026

-0.140

OPEN

$6.85

-2.04%

HIGH

$6.85

464,593

LOW

$6.73

TARGET
$7.89 17.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NOL . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx 41.1 44.3 xxx
DPS (cps) xxx 29.0 29.2 xxx
EPS Growth xxx 7.2% 7.8% xxx
DPS Growth xxx 0.0% 0.7% xxx
PE Ratio xxx N/A 15.0 xxx
Dividend Yield xxx N/A 4.4% xxx
Div Pay Ratio(%) xxx 70.6% 65.9% xxx

Dividend yield today if purchased 3 years ago: 3.78%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.36

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/09 - ex-div 16.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic 19.835.229.641.438.341.1
DPS All 14.024.022.028.029.029.0
Sales/Revenue 2,541.3 M2,597.6 M2,793.7 M3,121.7 M3,413.9 M3,563.2 M
Book Value Per Share 129.4151.1157.1200.3212.5225.7
Net Operating Cash Flow 211.6 M108.7 M337.6 M246.7 M257.1 M165.7 M
Net Profit Margin 3.55 %6.20 %4.86 %6.33 %5.47 %5.49 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed 14.96 %25.18 %19.25 %23.42 %18.69 %18.39 %
Return on Invested Capital 10.33 %17.24 %13.61 %17.39 %14.48 %14.42 %
Return on Assets 5.46 %9.20 %7.34 %9.56 %8.67 %9.09 %
Return on Equity 14.96 %25.18 %19.25 %23.42 %18.69 %18.39 %
Return on Total Capital 15.51 %24.29 %19.86 %26.08 %21.86 %20.04 %
Free Cash Flow ex dividends 104.6 M43.7 M221.5 M125.4 M109.5 M-7.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt 8 M9 M9 M9 M8 M23 M
Long Term Debt 307 M281 M303 M283 M299 M287 M
Total Debt 316 M290 M312 M292 M307 M310 M
Goodwill - Gross 227 M219 M236 M365 M371 M325 M
Cash & Equivalents - Generic 198 M214 M207 M243 M275 M229 M
Price To Book Value 3.564.314.704.223.463.14

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex 27.0 M23.6 M26.6 M52.3 M48.6 M53.6 M
Capex % of Sales 1.06 %0.91 %0.95 %1.68 %1.42 %1.50 %
Cost of Goods Sold ------
Selling, General & Admin. Exp & Other 448 M360 M506 M597 M184 M70 M
Research & Development ------
Investments - Total 838 M878 M1,018 M1,077 M1,091 M1,124 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

5

xxxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

29/10/2025

3

Equal-weight

$7.85

16.64%

Morgan Stanley has outlined upcoming catalysts for Australian non-bank financial stocks which could influence share price performance through to year end.

At nib Holdings' AGM, Morgan Stanley is anticipating an update on year-to-date performance to October 2025. The broker will focus on policyholder growth in the Australian resident segment, where it forecasts 2.9% FY26 growth vs 2.6% consensus.

In New Zealand, the analysts expect breakeven profitability in 1H26, compared with consensus forecasts of a $4m profit.

Morgan Stanley's last recorded target and rating in the FNArena database for nib Holdings were $7.85 and Equal-weight, respectively. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 29.30 cents and EPS of 41.80 cents.
Morgan Stanley forecasts a full year FY27 dividend of 32.90 cents and EPS of 46.90 cents.

Ord Minnett

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

25/08/2025

2

Overweight

$8.00

18.87%

Jarden highlights nib Holdings' FY25 net profit was solid, 8.5% ahead of its profit and 10.9% higher than consensus, though the beat was more modest when tax benefit from historical tax losses is stripped out.

The result showed NZ business remediation is tracking faster than expected based on pricing and inflation trends. Progress toward profitability in health services continues and further cost-out opportunities were identified across the group.

The company guided to a positive group underlying operating profit for FY26 driven by Australian health insurance, NZ and momentum in adjacent businesses. 

Overweight. Target lifted to $8.00 from $7.75.

FORECAST
Jarden forecasts a full year FY26 dividend of 28.00 cents and EPS of 43.60 cents.
Jarden forecasts a full year FY27 dividend of 30.00 cents and EPS of 46.70 cents.
Access Extra Coverage Research History >

NHF STOCK CHART

FNArena News on NHF

1
Rudi’s View: Best Buys & Favourites For 2026

Dec 24 2025 - Rudi's View
2
Rudi’s View: Copper, Aluminium & Technology (!)

Dec 11 2025 - Rudi's View
3
Rudi’s View: Amcor, Charter Hall, Challenger, Goodman, Woolworths & More

Nov 06 2025 - Rudi's View
4
Next Week At A Glance – 27-31 Oct 2025

Oct 24 2025 - Weekly Reports
5
Rudi’s View: Small Caps, Quality, Gold, Balance & Maximum Diversification

Oct 16 2025 - Rudi's View

Latest Insurance News

1
ASIC Watch: Ai Governance Tax Hits Insurers

Dec 22 2025 - Australia
2
Insurance Sector’s AI Challenges Have Arrived

Nov 03 2025 - Australia
3
Insurers To Pamper Shareholders With Buybacks

Jan 24 2025 - Australia
4
IAG Shares Breaking Out

Jan 21 2025 - Technicals
5
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
6
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
7
Steadfast’s Long March

Jul 02 2024 - Australia
8
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
9
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
10
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories